Friday, August 26, 2011

Bayer AG Outlook

Bayer AG is a result oriented research company. having many innovative research drug discoveries to its credit. Not only Asperin, Resochin , Canesten, Cipro,Glucobay,( eye disease treatment Eylea, blood thinner Xarelto, and Alpharadin .... in the pipeline) The German company—which gave the world aspirin—also has three other promising drug assets—Lemtrada for multiple sclerosis, Regorafenib for colorectal cancer, and pulmonary hypertension therapy Riociguat.It is a company in which the ailing world can see ray of hope for their better tomorrow

No comments: